Business Context and Reporting Period
This Form 8-K is filed by TRxADE HEALTH, Inc. (trading symbol: MEDS) on November 20, 2023. The report addresses the company's failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2023, within the five-day grace period provided by Rule 12b-25.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the status of the pending financial report rather than disclosing new financial data.
Material Changes and Events
- Delayed Filing: The company previously notified the SEC of a delay in filing its Q3 2023 Form 10-Q due to the time required to prepare financial statements.
- Grace Period Expiration: The company confirmed it could not complete the Form 10-Q within the initial five-day grace period.
- Auditor Status: Independent auditors have been unable to complete their review of the financial statements to date.
Outlook, Risks, and Management Commentary
Management expects to file the Form 10-Q by December 15, 2023. As a result of the filing delay, the company anticipates receiving a notice of non-compliance from The Nasdaq Stock Market LLC. Management expects this notice will include a grace period to regain compliance with Nasdaq Listing Rules and intends to file the report within that timeframe.
Investor Verification Checklist
- Verify the actual filing date of the Form 10-Q for the period ended September 30, 2023, against the December 15, 2023 target.
- Monitor Nasdaq communications for the specific terms of the non-compliance notice and the granted grace period.
- Review the eventual Form 10-Q for details on the reasons for the delay and any restatements or auditor qualifications.
- Check for any subsequent 8-K filings regarding delisting proceedings if the December 15 deadline is missed.